A norleucine-resistant mutant was derived from an isoleucine-valine auxotroph of a leucine accumulator of Serratia marcescens. The norleucine-resistant mutant could accumulate norleucine from norvaline in the medium without the addition of methionine, which antagonized norleucine. This mutant constitutively formed homoserine-O-transsuccinylase.
Norleucine is a well-known antagonist of methionine in many microorganisms (1, 3, 10) . As reported previously, we found that norleucine is synthesized from a-ketovalerate, an a-ketoacid corresponding to norvaline, by the leucine biosynthetic enzymes in Serratia marcescens (6) . Therefore, an isoleucine-valine auxotroph of a leucine accumulator, which was released from the regulation in leucine biosynthesis, was expected to accumulate norleucine from norvaline. However, the auxotroph did not grow in a medium containing norvaline in the absence of methionine. The addition of methionine reversed this growth inhibition and brought about norleucine accumulation (6) . These results suggest that norleucine inhibits methionine biosynthesis in S. marcescens. In this report, we describe the mechanism of inhibition of methionine biosynthesis by norleucine and norleucine accumulation from norvaline by a norleucine-resistant mutant.
MATERIALS AND METHODS Bacteria. S. marcescens no. 1 (4) and its mutants were used. Strain S-IV-7 (6) is an isoleucine-valine auxotroph of leucine accumulator S-11 (5) . Strain NLr8290 is a norleucine-resistant mutant derived from strain S-IV-7.
Isolation of the norleucine-resistant mutant. Strain S-IV-7 was treated with N-methyl-N'-nitro-N-nitrosoguanidine and grown for 3 days on an agar plate containing the modified minimal medium of Davis and Mingioli (2) . The medium lacked citrate and contained 0.5% glucose and 10 mg of DL-norleucine per ml, together with Chemicals. The amino acids used were all L-form unless otherwise noted. Succinyl-coenzyme A was prepared by the method of Lawrence (10) . Other chemicals were of reagent grade.
Enzyme assay. Cell-free extracts were prepared as described previously (6) . Homoserine-O-transsuccinylase (HOTS) was assayed by a modification of the method of Lawrence (10) as follows. The reaction mixture contained 2.5 ,umol of homoserine, 0.6 ,umol of succinyl-coenzyme A, 5 g@mol of potassium phosphate (pH 7.5), and cell-free extract (0.3 to 1.0 mg of protein), in a total volume of 0.5 ml. The reaction was started by adding succinyl-coenzyme A to the mixture. The reaction was carried out at 30°C for 10 min and stopped by adding 1.5 ml of ice-cold ethanol. One milliliter of the reaction mixture was added to a tube containing 2 ml of ice-cold 10-4 M 5,5-dithio-bis-2-nitrobenzoic acid in 10-1 M potassium phosphate (pH 7.0 CaCO3, pH 7.0. Norvaline was added to the medium at 10 mg/ml. Isoleucine, valine, leucine, and methionine were added to the medium at 0.2 to 1.0 mg/ml, if necessary. Incubation was carried out at 30°C for 72 h with reciprocal shaking (140 rpm, 8-cm stroke). The growth was estimated by measuring the optical density at 660 nm of fermentation broth diluted with 0.1 N HCl and was expressed as dry cell weight calculated from a standard curve. Norleucine and norvaline were determined by paper chromatography as described previously (7) .
RESULTS
Growth inhibition by norleucine. As previously reported (6), strain S-IV-7 did not grow in a medium containing norvaline in the absence of methionine. Addition of methionine to the medium resulted in normal growth and norleucine accumulation. The inhibition probably is attributable to norleucine formed from norvaline. Therefore, growth inhibition by norleucine was examined. Norleucine inhibited the growth of strain S-IV-7 (Fig. 1) . Growth inhibition by 10-2 M norleucine was reversed by the addition of 10-4 M methionine.
Norleucine accumulation by the norleucine-resistant mutant. To derive the norleucine accumulator from strain S-IV-7, we isolated a mutant which could grow even in the presence of norleucine and absence of methionine. In the norleucine-resistant mutant NLr8290, growth was not inhibited by 10-2 M norleucine (Fig. 2) . Then, accumulation of norleucine from norvaline was examined (Table  1) . Strain NLr8290 showed normal growth and accumulated a large amount of norleucine even in the absence of methionine, although strain S-IV-7 could grow and accumulate norleucine only in the presence of methionine.
Feedback controls of HOTS. In Salmonella typhimurium, methionine inhibits the activity of HOTS, the first enzyme of methionine biosynthesis, and represses the formation of all the enzymes ofthe pathway (12) . Therefore, release of both feedback controls would result in an increase in the intracellular level of methionine. To elucidate the mechanism of norleucine resistance in strain NLr8290, feedback controls of HOTS in S. marcescens were examined. First, formation HOTS was investigated (Table   0. 2). In strain S-IV-7, HOTS was derepressed by norleucine, and the addition of methionine overcame the derepression. Next, feedback inhibition of HOTS was investigated by using the enzyme derepressed by norleucine (Table 3 ). The activity of HOTS was inhibited by norleucine as well as methionine. These findings suggest that the cause of the growth inhibition by norleucine in strain S-IV-7 is the decrease of APPL. ENVIRON. MICROBIOL. methionine synthesis due to the false feedback inhibition of HOTS by norleucine. Similarly, feedback controls of HOTS in the norleucineresistant mutant NLr8290 were investigated (Table 4) . In this strain, HOTS was formed constitutively but was not released from feedback inhibition. In strain S-IV-7, addition of methionine was required for the reversal of growth inhibition by norleucine (see Fig. 1 ). Therefore, in strain NLr8290, constitutive formation of HOTS is probably enough to supply the necessary amount of methionine for normal growth, although feedback inhibition was not released. DISCUSSION In S. marcescens, norleucine caused growth inhibition. Therefore, for norleucine accumulation, release from the regulation of norleucine biosynthesis and overcoming the growth inhibition by norleucine are necessary. Norleucine is synthesized by the leucine biosynthetic enzymes owing to the broad substrate specificities of the enzymes, and its formation is regulated by leucine but not by norleucine (6) . Accordingly, we have derived a norleucine-resistant mutant from a leucine accumulator, a strain released from the feedback controls of leucine biosynthesis. The norleucine-resistant mutant was able to accumulate norleucine even in the medium without methionine. In S. marcescens, as in S. typhimurium (11) , HOTS was found to be subject to feedback controls by methionine. The norleucine-resistant mutant constitutively formed HOTS, although the feedback inhibition of the enzyme was not released. The mutant could normally grow in the presence of norleucine without addition of methionine. These findings suggest that the HOTS activity ofthe norleucine-resistant mutant in vivo is not inhibited completely by norleucine and that the constitutive formation of HOTS is probably enough to supply the necessary amount of methionine for normal growth. This idea might be supported by our previous results that 10% Lthreonine dehydratase activity in the wild-type strain is sufficient to support the normal growth rate (9) .
The mode of formation of unnatural amino acids may be divided into three groups: formation by the conversion of natural amino acids, formation by novel routes, and formation by the biosynthetic pathways associated with the synthesis of natural amino acids. Biosynthesis of norleucine belongs to the third group. To accumulate an unnatural amino acid in this group, release from the regulation of natural amino acid biosynthesis associated with the synthesis of the unnatural amino acids is necessary. Furthermore, when an unnatural amino acid acts as an antimetabolite, overcoming the growth inhibition by the amino acid is also necessary. This norleucine accumulation by an S. marcescens mutant is an example of antimetabolite accumulation by the endowment of antimetabolite resistance to the microorganism, which is released from the regulation of natural amino acid biosynthesis.
Norvaline was accumulated from L-threonine by the regulatory mutant constructed by the transducing method in S. marcescens Sr41 (8) . Accordingly, norleucine accumulation from glucose via L-threonine was also investigated and will be reported in a separate paper. 34, 1977 
